A new TB vaccine for adolescents and adults, developed by IIT and ILS Bhubaneswar, is set for commercialisation.

The vaccine triggers strong immune responses against Mycobacterium tuberculosis and is licensed for commercial development to ...

Initial blood work found hints of an infection, and the doctors initially suspected a bacterial skin infection (cellulitis) ...

Bhubaneswar: The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS) along with the ...

If you are also suffering from a bacterial infection and have waited long enough for its natural recovery you may need a Swab ...

“To address this critical unmet need, a next-generation HSP Subunit Vaccine has been developed through collaborative research ...

Bhubaneswar and Institute of Life Sciences (ILS) along with National Research Development Corporation (NRDC) o ...

The Global TB Report 2025 released by the World Health Organization (WHO) highlights that India’s TB incidence has reduced ...

Prominent Nontuberculous Mycobacterial (NTM) Infections emerging therapies include ALIS, Antimycobacterial regimen, ...

The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS) along with the ...

BCG (Bacillus Calmette - Guerin) vaccine is made from a treated (attenuated) live strain of bacterium derived from Mycobacterium bovis, a bacterium which typically causes tuberculosis (TB) in cattle ...

The HSP Subunit Vaccine candidate, jointly developed by the Institute of Life Sciences (ILS), Bhubaneswar, and the Indian Institute of Technology (IIT) Bhubaneswar, marks a significant advancement in ...